SUNZEN | SUNZEN BIOTECH BERHAD [NS]
0.320 (1.59%)
T-O (am): 0.315 (08:59:00)
Last updated: 17:00
iSaham Fundamental Trend
FCON: | Sharpe Ratio: | LTS:
Quarter Reports
Select columns required and click "Update" to save your preferences
| Ann. Date | Qtr. Date | Q | FYE | Revenue [M] | PBT [M] | NP [M] | NPM | DPS | EPS | R. QoQ | R. YoY | E. QoQ | E. YoY | TTM EPS |
Adj. [M] |
NP [M] (adj) |
NPM (adj) |
EPS (adj) |
E. QoQ (adj) |
E. YoY (adj) |
TTM EPS (adj) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29 Feb 24 | 31 Dec 23 | Other | 30 Jun 24 | 29.34 | 4.84 | 3.11 | 10.6% | 0.00 | 0.44 | 12.9% | 72.2% | 83.7% | 172.6% | ||||||||
| 29 Nov 23 | Q3 Sep 23 | 3 | 31 Dec 23 | 25.98 | 3.18 | 1.69 | 6.5% | 0.00 | 0.24 | 31.4% | 8.7% | 83.8% | 78.0% | ||||||||
| 30 Aug 23 | Q2 Jun 23 | 2 | 31 Dec 23 | 19.77 | 1.71 | 0.92 | 4.7% | 0.00 | 0.13 | 14.2% | 28.7% | 14.2% | 14.7% | ||||||||
| 26 May 23 | Q1 Mar 23 | 1 | 31 Dec 23 | 23.04 | 2.04 | 1.07 | 4.7% | 0.00 | 0.15 | 35.2% | 19.0% | 5.9% | 44.9% | ||||||||
| 23 Feb 23 | Q4 Dec 22 | 4 | 31 Dec 22 | 17.04 | 1.64 | 1.14 | 6.7% | 0.00 | 0.16 | 28.7% | 41.2% | 20.0% | 71.1% | ||||||||
| 29 Nov 22 | Q3 Sep 22 | 3 | 31 Dec 22 | 23.89 | 1.71 | 0.95 | 4.0% | 0.00 | 0.14 | 13.9% | 37.0% | 18.4% | 1239.4% | ||||||||
| 30 Aug 22 | Q2 Jun 22 | 2 | 31 Dec 22 | 27.74 | 1.84 | 0.80 | 2.9% | 0.00 | 0.12 | 2.4% | 36.3% | 8.4% | 351.1% | ||||||||
| 26 May 22 | Q1 Mar 22 | 1 | 31 Dec 22 | 28.43 | 2.16 | 0.74 | 2.6% | 0.00 | 0.12 | 1.9% | 20.2% | 11.1% | 439.9% | ||||||||
| 25 Feb 22 | Q4 Dec 21 | 4 | 31 Dec 21 | 29.00 | 2.10 | 0.67 | 2.3% | 0.00 | 0.12 | 66.2% | 4.1% | 839.4% | 107.8% | ||||||||
| 24 Nov 21 | Q3 Sep 21 | 3 | 31 Dec 21 | 17.45 | 0.52 | 0.07 | 0.4% | 0.00 | 0.01 | 14.3% | 14.3% | 60.1% | 118.5% | ||||||||
| 27 Aug 21 | Q2 Jun 21 | 2 | 31 Dec 21 | 20.35 | 0.74 | 0.18 | 0.9% | 0.00 | 0.03 | 13.9% | 60.5% | 181.7% | 110.5% | ||||||||
| 28 May 21 | Q1 Mar 21 | 1 | 31 Dec 21 | 23.65 | 0.38 | -0.22 | -0.9% | 0.00 | -0.04 | 15.1% | 10.8% | 97.5% | 91.5% | ||||||||
| 25 Feb 21 | Q4 Dec 20 | 4 | 31 Dec 20 | 27.86 | -7.83 | -8.58 | -30.8% | 0.00 | -1.62 | 36.8% | 37.1% | 2141.2% | 32.8% | ||||||||
| 26 Nov 20 | Q3 Sep 20 | 3 | 31 Dec 20 | 20.36 | 0.13 | -0.38 | -1.9% | 0.00 | -0.07 | 60.6% | 67.2% | 77.4% | 90.7% | ||||||||
| 25 Aug 20 | Q2 Jun 20 | 2 | 31 Dec 20 | 12.68 | -1.82 | -1.70 | -13.4% | 0.00 | -0.32 | 40.6% | 81.8% | 34.0% | 30.2% | ||||||||
| 29 Jun 20 | Q1 Mar 20 | 1 | 31 Dec 20 | 21.34 | -3.19 | -2.57 | -12.0% | 0.00 | -0.49 | 51.8% | 68.1% | 79.9% | 167.2% | ||||||||
| 27 Feb 20 | Q4 Dec 19 | 4 | 31 Dec 19 | 44.30 | -14.80 | -12.77 | -28.8% | 0.00 | -2.42 | 28.6% | 42.0% | 211.6% | 62.8% | ||||||||
| 28 Nov 19 | Q3 Sep 19 | 3 | 31 Dec 19 | 62.05 | -3.17 | -4.10 | -6.6% | 0.00 | -0.78 | 11.0% | 39.0% | 214.6% | 243.0% | ||||||||
| 22 Aug 19 | Q2 Jun 19 | 2 | 31 Dec 19 | 69.72 | -1.51 | -1.30 | -1.9% | 0.00 | -0.25 | 4.2% | 35.3% | 35.6% | 150.5% | ||||||||
| 30 May 19 | Q1 Mar 19 | 1 | 31 Dec 19 | 66.91 | -1.07 | -0.96 | -1.4% | 0.00 | -0.19 | 12.4% | 5.7% | 87.8% | 135.0% | ||||||||
| 28 Feb 19 | Q4 Dec 18 | 4 | 31 Dec 18 | 76.35 | -7.77 | -7.85 | -10.3% | 0.00 | -1.55 | 24.9% | 25.9% | 556.6% | 7299.1% | ||||||||
| 23 Nov 18 | Q3 Sep 18 | 3 | 31 Dec 18 | 101.63 | -1.55 | -1.20 | -1.2% | 0.00 | -0.24 | 97.3% | 29.1% | 146.3% | 236.7% | ||||||||
| 24 Aug 18 | Q2 Jun 18 | 2 | 31 Dec 18 | 51.52 | 2.84 | 2.58 | 5.0% | 0.00 | 0.53 | 27.4% | 32.1% | 730.8% | 75.3% | ||||||||
| 25 May 18 | Q1 Mar 18 | 1 | 31 Dec 18 | 70.93 | -0.45 | -0.41 | -0.6% | 0.00 | -0.09 | 31.2% | 55.1% | 475.2% | 140.1% | ||||||||
| 27 Feb 18 | Q4 Dec 17 | 4 | 31 Dec 17 | 103.09 | 0.12 | 0.11 | 0.1% | 0.00 | 0.02 | 30.9% | 634.1% | 87.5% | 95.0% | ||||||||
| 24 Nov 17 | Q3 Sep 17 | 3 | 31 Dec 17 | 78.74 | 1.40 | 0.87 | 1.1% | 0.30 | 0.18 | 3.8% | 896.3% | 40.6% | 217.5% | ||||||||
| 25 Aug 17 | Q2 Jun 17 | 2 | 31 Dec 17 | 75.88 | 1.43 | 1.47 | 1.9% | 0.00 | 0.31 | 65.9% | 658.1% | 44.5% | 507.8% | ||||||||
| 25 May 17 | Q1 Mar 17 | 1 | 31 Dec 17 | 45.74 | 1.06 | 1.02 | 2.2% | 0.00 | 0.21 | 225.8% | 467.6% | 53.7% | 183.1% | ||||||||
| 28 Feb 17 | Q4 Dec 16 | 4 | 31 Dec 16 | 14.04 | 1.79 | 2.20 | 15.7% | 0.00 | 0.49 | 77.7% | 57.4% | 396.1% | 587.4% | ||||||||
| 25 Nov 16 | Q3 Sep 16 | 3 | 31 Dec 16 | 7.90 | -0.73 | -0.74 | -9.4% | 0.00 | -0.18 | 21.0% | 27.6% | 106.1% | 59.3% | ||||||||
| 25 Aug 16 | Q2 Jun 16 | 2 | 31 Dec 16 | 10.01 | -0.30 | -0.36 | -3.6% | 0.00 | -0.10 | 24.2% | 10.3% | 70.6% | 302.8% | ||||||||
| 26 May 16 | Q1 Mar 16 | 1 | 31 Dec 16 | 8.06 | -1.21 | -1.23 | -15.2% | 0.00 | -0.40 | 9.7% | 0.3% | 171.5% | 412.2% | ||||||||
| 25 Feb 16 | Q4 Dec 15 | 4 | 31 Dec 15 | 8.92 | -0.47 | -0.45 | -5.1% | 0.00 | -0.16 | 44.1% | 15.5% | 3.2% | 182.3% | ||||||||
| 24 Nov 15 | Q3 Sep 15 | 3 | 31 Dec 15 | 6.19 | -0.41 | -0.47 | -7.5% | 0.00 | -0.17 | 31.7% | 26.8% | 362.4% | 5937.5% | ||||||||
| 28 Aug 15 | Q2 Jun 15 | 2 | 31 Dec 15 | 9.07 | 0.20 | 0.18 | 2.0% | 0.00 | 0.07 | 12.9% | 8.2% | 54.7% | 37.1% | ||||||||
| 25 May 15 | Q1 Mar 15 | 1 | 31 Dec 15 | 8.04 | 0.42 | 0.39 | 4.9% | 0.00 | 0.23 | 23.9% | 4.7% | 28.4% | 50.6% | ||||||||
| 25 Feb 15 | 31/12/14 | 4 | 31/12/14 | 10.56 | 0.61 | 0.55 | 5.2% | 0.00 | 0.33 | 24.8% | 9.1% | 6762.5% | 55.7% |
Historical Dividends
Financial Ratios
| EPS | 0.94 sen |
| Trailing PE (Sector Median: 13.0) | 33.8 |
| PEG | 0.34 |
| Altman Z | 1.2 |
| Beaver | -1.553 |
| Current Ratio | 5.6 |
| Debt-Equity (DE) Ratio | 0.16 |
| FCF Yield | -14.96 % |
| Revenue QoQ | 12.92 % |
| Revenue YoY | 72.21% |
| Profit QoQ | 83.7 % |
| Profit YoY | 172.57 % |
| Profit Margin (Sector Median: 5.4) | 6.93 % |
| ROE (ROIC: 5.03) | 5.28 % |
| Dividend Per Share (DPS) | 0.0 sen |
| Dividend Yield (DY) | 0.0 % |
Adjusted Financial Ratios
Ratios below have been recalculated after adjusting for One Off Gain/Loss detected from Quarterly reports
| EPS | |
| Trailing PE (Sector Median: 13.0) | |
| Profit QoQ | |
| Profit YoY | |
| Profit Margin (Sector Median: 5.4) | |
| ROE (ROIC: 5.33) | |
| Altman Z |
Fair Value
Weighted Average Fair Value:
| Discounted Cash Flow (DCF) 5% Growth | |
| Discounted Cash Flow (DCF) 10% Growth | |
| Relative Valuation |
| Graham Formula | |
| Graham Number | |
| Net Tangible Asset (NTA) | 0.18 | Consistent QR FV |
Advanced Calculators
Calculate the fair value of the stock based on expected growth / risk, contract / award value, forecasted profit or forecasted revenue.
| Forward PE FV Calculator | |
| Latest Profit (adjusted) [M] | 3.11 |
| Expected Profit (Next QR) [M] | |
| Expected Profit (After QR above) [M] | |
| Expected Profit (After QR above) [M] | |
| Estimated Fair Value |
| Growth/Risk Fair Value Calculator | |
| Expected growth (%) | |
| Estimated downside / risk (%) | |
| Estimated New DCF Fair Value |
| Contract/Award Contribution Calculator | |
| Contract/Award Value (in Million) | |
| Estimated Contribution to Stock Price | |
| Estimated New DCF Fair Value |
| Profit-Based Calculator | |
| Expected Profit (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Revenue-Based Calculator | |
| Expected Revenue (M) | |
| for Year | |
| Estimated New DCF Fair Value |
| Market Pricing | |
| Expected Profit (M) | 0.0 |
| Expected Revenue (M) | 0.0 |
| Expected Growth (%) | 0.0 |
Directors Share Purchases (Beta)
MISS POO LONG YII added 17000.0 units announced on 18 Jan 2024 at ~RM0.22
MISS POO LONG YII added 83000.0 units announced on 12 Jan 2024 at ~RM0.29
DR FONG CHAN SENG added 100000.0 units announced on 18 Sep 2020 at ~RM0.185
MR TEO YEK MING reduced 500000.0 units announced on 03 Sep 2020 at ~RM0.15
Summary
Market Cap: 230 M.
Number of Shares: 721 M.
Adjusted Float: 71.2%.
Stock highly correlated with
OFI (93%)
CRESNDO (92%)
EPICON (92%)
EDARAN (90%)
The principal activities of Sunzen Biotech Berhad are investment holding and manufacturing of animal health products. The principal activities of the subsidiaries are R&D; and commercialisation of in-feed anti bacterial products and supplements for animal health products, distribution amd marketing of animal health products. Sunzen Biotech Berhad was incorporated in Malaysia on 8 February 2005 as a public limited company. The group consists of Sunzen Biotech and wholly owned subsidiaries namely Sunzen Corporation, Sunzen LifeSciences and Sunzen Feedtech. The principle activities of the company is investment holding whilst it subsidiaries are involved in the manufacturing of animal health products focused in animal feed additive market to feed millers and livestock producers across Asian markets. The company manufactures and distributes its own brand of products mainly locally.
Sectors: Penny Stocks, Agricultural Products, Consumer Products & Services
Code: 0148
Website: http://www.sunzen.com.my/
Related Links: Bursa | Annual Report | Announcement
Warrant Info:
| Symbol | Price | Ex.Price | Premium | Expiry |
|---|---|---|---|---|
| SUNZEN-WC [NS] | 0.135 | 0.2 | 4.69% | 13-Sep-2027 |
Top Shareholdings
Updated on 31-Mar-2023
| Shareholder | % | Value (M) |
|---|---|---|
| Teo Yek Ming | 16.88% | 38.95 |
| Chen Kim Lian | 9.46% | 21.83 |
| Madam Chen Kim Lian | 9.18% | 21.18 |
| Chum Mun Cuan | 5.38% | 12.42 |
| Kuan Ah Hock | 3.92% | 9.05 |
| Teow Wooi Huat | 3.69% | 8.52 |
| Koo Weng Seng | 2.55% | 5.89 |
| Teoh Shy Ming | 1.91% | 4.41 |
| Teow Chee Chow | 1.78% | 4.11 |
| Ow Boon Yonk | 1.76% | 4.06 |
| Jag Capital Equity Sdn. Bhd. | 1.75% | 4.04 |
| David Lai & Tan Services Sdn Bhd | 1.72% | 3.97 |
| Chang Tiam Hock | 1.57% | 3.62 |
| Lee Chee Hua | 1.56% | 3.6 |
| Wu Wai Kong | 1.42% | 3.28 |
| Lim Seng Lee | 1.42% | 3.28 |
| Goh Kok Foong | 1.42% | 3.28 |
| Global Mines Services Sdn Bhd | 1.32% | 3.05 |
| Leong Yee Keong | 1.31% | 3.02 |
| Chien Su Lang | 1.3% | 3.0 |
| Low Chee Yeap | 1.04% | 2.4 |
| Tan Wei Kent | 0.97% | 2.24 |
| Wong Pei Fern | 0.93% | 2.15 |
| Huam Hong Ping | 0.87% | 2.01 |
| Lim Eng Chai | 0.86% | 1.98 |
| Ooi Bee Hoon | 0.84% | 1.94 |
| Go Yoong Chang | 0.83% | 1.92 |
| Lim Wei Foon | 0.76% | 1.75 |
| Choong Kian Sun | 0.75% | 1.73 |
| Chew Kean Huat | 0.73% | 1.68 |
| Ching Chee Pun | 0.58% | 1.35 |
| Poo Long Yii | 0.01% | 0.03 |